Insider · CIK 0001728221
Robert Luther Huffines
Files at BDX (BECTON DICKINSON & CO), PODD (INSULET CORP), WBA (Walgreens Boots Alliance, Inc.), EIKN (Eikon Therapeutics, Inc.). First filing -, latest -.
Robert Luther Huffines files SEC Form 4 as director at BDX (BECTON DICKINSON & CO), and also at PODD (INSULET CORP), WBA (Walgreens Boots Alliance, Inc.), EIKN (Eikon Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert Luther Huffines has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | PODD INSULET CORP | AGrant or award Common Stock | +178 | $130.47 | $23k | 2,627 | 11 d ago |
| May 20, 2026 | PODD INSULET CORP | AGrant or award Common Stock | +1,660 | $0.00 | $0 | 2,298 | May 21, 2026 |
| May 8, 2026 | BDX BECTON DICKINSON & CO | AGrant or award Rights to Common Stock Under BD Deferred Compensation Planderivative | +210 | $149.04 | $31k | 404 | May 8, 2026 |
| Mar 31, 2026 | PODD INSULET CORP | AGrant or award Common Stock | +111 | $209.84 | $23k | 638 | Apr 2, 2026 |
| Mar 2, 2026 | EIKN Eikon Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +25,873 | $0.00 | $0 | 25,873 | Mar 4, 2026 |
| Feb 4, 2026 | BDX BECTON DICKINSON & CO | AGrant or award Rights to Common Stock Under BD Deferred Compensation Planderivative | +100 | $201.91 | $20k | 100 | Feb 5, 2026 |
| Jan 27, 2026 | BDX BECTON DICKINSON & CO | AGrant or award Common Stock | +1,098 | $0.00 | $0 | 1,279 | Jan 29, 2026 |
| Dec 31, 2025 | PODD INSULET CORP | AGrant or award Common Stock | +51 | $284.24 | $14k | 528 | Jan 6, 2026 |
| Dec 1, 2025 | BDX BECTON DICKINSON & CO | AGrant or award Common Stock | +180 | $0.00 | $0 | 180 | Dec 2, 2025 |
| Oct 31, 2025 | PODD INSULET CORP | AGrant or award Common Stock | +477 | $0.00 | $0 | 477 | Nov 3, 2025 |
| Aug 13, 2025 | WBA Walgreens Boots Alliance, Inc. | AGrant or award Phantom Stock Unitsderivative | +16,821 | $11.89 | $200k | 46,813 | Aug 15, 2025 |
| Jul 9, 2025 | WBA Walgreens Boots Alliance, Inc. | AGrant or award Phantom Stock Unitsderivative | +2,159 | $11.58 | $25k | 29,992 | Jul 11, 2025 |
| Apr 16, 2025 | WBA Walgreens Boots Alliance, Inc. | AGrant or award Phantom Stock Unitsderivative | +2,315 | $10.80 | $25k | 27,833 | Apr 18, 2025 |
| Jan 30, 2025 | WBA Walgreens Boots Alliance, Inc. | AGrant or award Phantom Stock Unitsderivative | +2,182 | $11.46 | $25k | 25,519 | Feb 3, 2025 |
| Nov 1, 2024 | WBA Walgreens Boots Alliance, Inc. | AGrant or award Phantom Stock Unitsderivative | +15,856 | $9.46 | $150k | 22,752 | Nov 5, 2024 |
| Oct 24, 2024 | WBA Walgreens Boots Alliance, Inc. | AGrant or award Phantom Stock Unitsderivative | +2,677 | $9.34 | $25k | 6,896 | Oct 28, 2024 |
Questions about Robert Luther Huffines
Answered from the filings on this page, as of the latest one.
Is Robert Luther Huffines buying or selling?
Robert Luther Huffines has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert Luther Huffines's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Luther Huffines has 0.
Where does Robert Luther Huffines file Form 4?
Robert Luther Huffines has filed Form 4 at BDX (BECTON DICKINSON & CO); PODD (INSULET CORP); WBA (Walgreens Boots Alliance, Inc.); EIKN (Eikon Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.